{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:43:58Z","timestamp":1786985038743,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Svenska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007231","name":"Cancerf\u00f6reningen i Stockholm","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012538","name":"Swedish Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012538","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001543","name":"Children's Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.bbrc.2011.06.120","type":"journal-article","created":{"date-parts":[[2011,6,26]],"date-time":"2011-06-26T15:09:51Z","timestamp":1309100991000},"page":"156-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["The pattern of gene expression and gene dose profiles of 6-Mercaptopurine- and 6-Thioguanine-resistant human leukemia cells"],"prefix":"10.1016","volume":"411","author":[{"given":"Hazhar","family":"Karim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamileh","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Moshfegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan K.","family":"Fotoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freidoun","family":"Albertioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2011.06.120_b0005","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.2174\/1381612033453677","article-title":"Thioguanine, mercaptopurine: their analogs and nucleosides as antimetabolites","volume":"9","author":"Elgemeie","year":"2003","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.bbrc.2011.06.120_b0010","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.bcp.2010.01.006","article-title":"Thiopurines: factors influencing toxicity and response","volume":"79","author":"Fotoohi","year":"2010","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.bbrc.2011.06.120_b0015","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.2217\/pgs.09.78","article-title":"Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond","volume":"10","author":"Karas-Kuzelicki","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.bbrc.2011.06.120_b0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1517\/14740330903426151","article-title":"Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status","volume":"9","author":"Stocco","year":"2010","journal-title":"Expert opinion on drug delivery"},{"key":"10.1016\/j.bbrc.2011.06.120_b0025","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF02220605","article-title":"The clinical pharmacology of 6-Mercaptopurine","volume":"43","author":"Lennard","year":"1992","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.bbrc.2011.06.120_b0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/mol.62.1.102","article-title":"The effect of thiopurine methyltransferase expression on sensitivity to thiopurine drugs","volume":"62","author":"Coulthard","year":"2002","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.bbrc.2011.06.120_b0035","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbrc.2006.02.134","article-title":"Involvement of the concentrative nucleoside transporter 3 and equilibrative nucleoside transporter 2 in the resistance of T-lymphoblastic cell lines to thiopurines","volume":"343","author":"Fotoohi","year":"2006","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.bbrc.2011.06.120_b0040","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1375\/twin.10.4.604","article-title":"Large-scale zygosity testing using single nucleotide polymorphisms","volume":"10","author":"Hannelius","year":"2007","journal-title":"Twin research and human genetics"},{"key":"10.1016\/j.bbrc.2011.06.120_b0045","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.bcp.2008.12.026","article-title":"Gene expression profiling of leukemia T-cells resistant to methotrexate and 7-hydroxymethotrexate reveals alterations that preserve intracellular levels of folate and nucleotide biosynthesis","volume":"77","author":"Fotoohi","year":"2009","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.bbrc.2011.06.120_b0050","doi-asserted-by":"crossref","first-page":"e14757","DOI":"10.1371\/journal.pone.0014757","article-title":"Molecular Characterization of Acquired Tolerance of Tumor Cells to Picropodophyllin (PPP)","volume":"6","author":"Hashemi","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbrc.2011.06.120_b0095","doi-asserted-by":"crossref","unstructured":"L.H. Saal, C. Troein, J. Vallon-Christersson, S. Gruvberger, A. Borg, and C. Peterson, BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data, Genome Biology 3 (2002) SOFTWARE0003.","DOI":"10.1186\/gb-2002-3-8-software0003"},{"key":"10.1016\/j.bbrc.2011.06.120_b0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1152\/physiolgenomics.00020.2001","article-title":"A statistical method for flagging weak spots improves normalization and ratio estimates in microarrays","volume":"7","author":"Yang","year":"2001","journal-title":"Physiological genomics"},{"key":"10.1016\/j.bbrc.2011.06.120_b0065","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/bioinformatics\/btg230","article-title":"CGH-Plotter: MATLAB toolbox for CGH-data analysis","volume":"19","author":"Autio","year":"2003","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbrc.2011.06.120_b0070","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0006-291X(73)91346-6","article-title":"Terminal deoxynucleotidyl transferase activity in a cell line (molt-4) derived from the peripheral blood of a patient with acute lymphoblastic leukemia","volume":"51","author":"Sahai Srivastava","year":"1973","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.bbrc.2011.06.120_b0075","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1309\/L3UW-3AE7-L4LB-3QX3","article-title":"Terminal deoxynucleotidyl transferase-positive lymphoid cells in reactive lymph nodes from children with malignant tumors: incidence, distribution pattern, and immunophenotype in 26 patients","volume":"118","author":"Onciu","year":"2002","journal-title":"American Journal of Clinical Pathology"},{"key":"10.1016\/j.bbrc.2011.06.120_b0080","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1309\/QD18PPV1NH3TEUTF","article-title":"Nonpositive terminal deoxynucleotidyl transferase in pediatric precursor B-lymphoblastic leukemia","volume":"121","author":"Liu","year":"2004","journal-title":"American Journal of Clinical Pathology"},{"key":"10.1016\/j.bbrc.2011.06.120_b0085","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.2174\/092986706777935087","article-title":"Human terminal deoxynucleotidyl transferases as novel targets for anticancer chemotherapy","volume":"13","author":"Di Santo","year":"2006","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.bbrc.2011.06.120_b0090","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1042\/bj3580225","article-title":"Structure and expression of human mitochondrial adenylate kinase targeted to the mitochondrial matrix","volume":"358","author":"Noma","year":"2001","journal-title":"Biochemical Journal"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X11011004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X11011004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:24:57Z","timestamp":1762093497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X11011004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0006291X11011004"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2011.06.120","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pattern of gene expression and gene dose profiles of 6-Mercaptopurine- and 6-Thioguanine-resistant human leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2011.06.120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}